2024-04-17  10:10:00 PM Chg. +0.71 Volume Bid1:59:59 AM Ask1:59:59 AM Market Capitalization Dividend Y. P/E Ratio
84.88USD +0.84% 359,409
Turnover: 20.35 mill.
83.32Bid Size: 100 86.88Ask Size: 100 4.31 bill.USD - 37.39

Business description

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for their customers.
 

Management board & Supervisory board

CEO
Christopher Simon
Management board
James C. D'Arecca, Michelle L. Basil, Kerri DiPietro, Roy Galvin, Jan Hartmann, Anila Lingamneni, Josep Lluis Llorens, Laurie Miller, Stewart W. Strong, Rajeev Varma
Supervisory board
Ellen M. Zane, Mark W. Kroll, Christopher A. Simon, Robert E. Abernathy, Diane M. Bryant, Michael J. Coyle, Charles J. Dockendorff, Lloyd E. Johnson, Claire Pomeroy
 

Company data

Name: Haemonetics Corporation
Address: 125 Summer Street,Boston, MA 02110, USA
Phone: +1-781-848-7100
Fax: -
E-mail: -
Internet: www.haemonetics.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 03-31
Free Float: 70.25%
IPO date: -

Investor relations

Name: Olga Guyette
IR phone: +1-781-356-9763
IR Fax: -
IR e-mail: investor@haemonetics.com

Main Shareholders

Freefloat
 
70.25%
The Vanguard Group, Inc.
 
9.52%
BlackRock, Inc.
 
9.22%
Neuberger Berman Group LLC
 
5.56%
Capital Research Global Investors
 
5.45%